Mechanisms of the blunting of the sympatho-adrenal response: A theory

Current Diabetes Reviews

Volumn 5, Issue 2, 2009, Pages 79-91

  Parekh, B ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Brain glycogen; Defective arousal; Glucose sensing; Hypoglycaemia unawareness; Insulin therapy; Noradrenaline

Indexed keywords

4 AMINOBUTYRIC ACID; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; DIAZOXIDE; GLIBENCLAMIDE; GLUCOKINASE; GLYCOGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LACTIC ACID; LUTEINIZING HORMONE; MONOCARBOXYLATE TRANSPORTER; MONOCARBOXYLATE TRANSPORTER 2; NITRIC OXIDE; OREXIN A; TOLBUTAMIDE; NORADRENALIN;

4 AMINOBUTYRIC ACID RELEASE; ADRENALIN RELEASE; ADRENERGIC ACTIVITY; ADRENERGIC TRANSMISSION; ANXIETY DISORDER; BLUNTING OF THE SYMPATHOADRENAL RESPONSE; BRAIN CORTEX; BRAIN FUNCTION; BRAIN METABOLISM; CHANNEL GATING; CHOLINERGIC NERVE CELL; CITRIC ACID CYCLE; DRUG MECHANISM; ENZYME ACTIVITY; EXERCISE; GABAERGIC SYSTEM; GABAERGIC TRANSMISSION; GLUCOSE METABOLISM; GLYCOGEN METABOLISM; HUMAN; HYPOGLYCEMIA; HYPOTHALAMUS VENTROMEDIAL NUCLEUS; INSULIN DEPENDENT DIABETES MELLITUS; LATERAL HYPOTHALAMUS; NEUROANATOMY; NEUROENDOCRINE SYSTEM; NEUROPATHOLOGY; NONHUMAN; NORADRENALIN RELEASE; NORADRENERGIC NERVE; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; PROTEIN CARBOHYDRATE INTERACTION; RECEPTOR DOWN REGULATION; REVIEW; SEX DIFFERENCE; SLEEP AROUSAL DISORDER; STRUCTURE ACTIVITY RELATION; THEORY; ADRENAL MEDULLA; ADRENERGIC SYSTEM; ANIMAL; BRAIN; PATHOPHYSIOLOGY; PHYSIOLOGY; SEXUAL DEVELOPMENT; SLEEP;

ADRENAL MEDULLA; ANIMALS; BRAIN; EXERCISE; HUMANS; HYPOGLYCEMIA; NOREPINEPHRINE; SEX CHARACTERISTICS; SLEEP; SYMPATHETIC NERVOUS SYSTEM;

EID: 68349105188     PISSN: 15733998     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339909788166846     Document Type: Review

References (157)

1. Cryer PE. Mechanisms of hypoglycaemia-associated autonomic failure and its component syndromes in diabetes. Diabetes 2005; 54(12): 3592-601.
2. Cryer PE, Childs BP. Negotiating the Barrier of Hypoglycemia in Diabetes. Diabetes Spectr 2002; 15(1): 20-7.
3. Levin BE, Sullivan AC. Glucose, insulin and sympathoadrenal activation. Auton Nerv Syst 1987; 20(3): 233-42.
4. Towler DA, Havlin CE, Craft S, Cryer PE. Mechanism of awareness of hypoglycaemia: perception of neurogenic (predominantly cholinergic) rather than neuroglycopenic symptoms. Diabetes 1993; 42: 1791-8.
5. Bolli GB. Counterregulatory mechanisms to insulin-induced hypoglycemia in humans: relevance to the problem of intensive treatment of IDDM. J Pediatr Endocrinol Metab 1998; 11(1): 103-15.
6. Amiel SA, Archibald HR, Chusney G, Williams AJ, Gale EA. Ketone infusion lowers hormonal responses to hypoglycaemia: evidence for acute cerebral utilization of a non-glucose fuel. Clin Sci (Lond) 1991; 81(2): 189-94.
7. Evans ML, Matyka K, Lomas J, et al. Reduced counterregulation during hypoglycaemia with raised circulating nonglucose lipid substrates: evidence for regional differences in metabolic capacity in the human brain? Clin Endocrinol Metab 1998; 83(8): 2952-9.
8. Maran A, Crepaldi C, Trupiani S, et al. Brain function rescue effect of lactate following hypoglycaemia is not an adaptation process in both normal and type 1 diabetic subjects. Diabetologia 2000; 43(6): 733-41.
9. Maran A, Cranston I, Lomas J, Macdonald I, Amiel SA. Protection by lactate of cerebral function during hypoglycaemia. Lancet 1994; 343(8888): 16-20.
10. Davis M, Mellman M, Friedman S, Chang CJ, Shamoon H. Recovery of epinephrine response but not hypoglycemic symptom threshold after intensive therapy in type 1 diabetes. Am J Med 1994; 97: 535-42.
11. Davis SN, Mann S, Galassetti P, et al. Effects of differing durations of antecedent hypoglycemia on counterregulatory responses to subsequent hypoglycemia in normal humans. Diabetes 2000; 49(11): 1897-903.
12. Magistretti PJ, Sorg O, Yu N, Martin JL, Pellerin L. Neurotransmitters regulate energy metabolism in astrocytes: implications for the metabolic trafficking between neural cells. Dev Neurosci 1993; 15(3-5): 306-12.
13. Gruetter R. Glycogen: the forgotten cerebral energy store. J Neurosci Res 2003; 74: 179-83.
14. Choi IY, Seaquist ER, Gruetter R. Effect of hypoglycemia on brain glycogen metabolism in vivo. Neurosci Res 2003; 72(1): 25-32. [15] Alquier T, Kawashima J, Tsuji Y, Kahn BB. Role of hypothalamic adenosine 5′-monophosphate-activated protein kinase in the impaired counterregulatory response induced by repetitive neuroglucopenia. Endocrinology 2007; 148(3): 1367-75.
15. Oz G, Kumar A, Rao JP, Seaquiest E. Human brain glycogen utilization during moderate hypoglycaemia. (Abstract) (2007-166-OR-Diabetes) ADA annual 67th scientific sessions.
16. Elekes O, Venema K, Postema F, Dringen R, Hamprecht B, Korf J. Evidence that stress activates glial lactate formation in vivo assessed with rat hippocampus lactography. Neurosci Lett 1996; 208(1): 69-72.
17. Kraemer WJ, Patton JF, Knuttgen HG, et al. Effects of high-intensity cycle exercise on sympathoadrenal-medullary response patterns. J Appl Physiol 1991; 70(1): 8-14.
18. Kemppainen J, Aalto S, Fujimoto T, et al. High intensity exercise decreases global brain glucose uptake in humans. J Physiol 2005; 568(Pt 1): 323-32.
19. Ide K, Horn A, Secher NH. Cerebral metabolic response to submaximal exercise. J Appl Physiol 1999; 87: 1604-8.
20. Barnes M, Lawson MA, Doane DF, Beverly JL. Glycogen in the VMH influences local glucose and lactate concentrations during hypoglycemia in rats and may contribute to HAAF. (Abstract) (2007-0380-OR-Diabetes) ADA annual 67th scientific sessions.
21. Herzog RI, Chan O, Yu S, et al. Effect of acute and recurrent hypoglycemia on changes in brain glycogen concentration. Endocrinology 2008; 149(4): 1499-504.
22. Sherwin RS. Bringing light to the dark side of insulin: a journey across the blood-brain barrier. Diabetes 57(9): 2259-68.
23. McCrimmon R. The mechanisms that underlie glucose sensing during hypoglycaemia in diabetes. Diabet Med 2008; 25(5): 513-22.
24. Routh VH. Glucosensing neurons in the ventromedial hypothalamic nucleus (VMN) and hypoglycemia-associated autonomic failure (HAAF). Diabet Metab Res Rev 2003; 19(5): 348-56.
25. Song Z, Levin BE, McArdle JJ, Bakhos N, Routh VH. Convergence of pre- and postsynaptic influences on glucosensing-neurons in the ventromedial hypothalamic nucleus. Diabetes 2001; 50: 2673-81.
26. Borg WP, During MJ, Sherwin RS, Borg MA, Brines ML, Shulman GI. Ventromedial hypothalamic lesions in rats suppress counter-regulatory responses to hypoglycemia. J Clin Invest 1994; 93: 1677-82.
27. Borg WP, Sherwin RS, During MJ, Borg MA, Shulman GI. Local ventromedial hypothalamus glucopenia triggers counterregulatory hormone release. Diabetes 1995; 44: 180-4.
28. Borg MA, Sherwin RS, Borg WP, Tamborlane WV, Shulman GI. Local ventromedial hypothalamus glucose perfusion blocks counter-regulation during systemic hypoglycemia in awake rats. J Clin Invest 1997; 99: 361-5.
29. Evans ML, McCrimmon RJ, Flanagan DE, et al. Hypothalamic ATP-sensitive K + channels play a key role in sensing hypoglycemia and triggering counterregulatory epinephrine and glucagon responses. Diabetes 2004; 53(10): 2542-51.
30. McCrimmon RJ, Evans ML, Fan X, et al. Activation of ATP-sensitive K+ channels in the ventromedial hypothalamus amplifies counterregulatory hormone responses to hypoglycemia in normal and recurrently hypoglycemic rats. Diabetes 2005; 54(11): 3169-74.
31. Chan O, Lawson M, Zhu W, Beverly JL, Sherwin RS. ATP-sensitive K(+) channels regulate the release of GABA in the ventromedial hypothalamus during hypoglycemia. Diabetes 2007; 56(4): 1120-6.
32. Bingham E, Hopkins D, Pernet A, Reid H, Macdonald IA, Amiel SA. The effects of KATP channel modulators on counterregulatory responses andcognitive function during acute controlled hypoglycaemia in healthy men: a pilot study. Diabet Med 2003; 20(3): 231-7.
33. Miki T, Liss B, Minami K, et al. ATP-sensitive K+ channels in the hypothalamus are essential for the maintenance of glucose homeostasis. Nat Neurosci 2001; 4(5): 507-12.
34. Crépel V, Rovira C, Ben-Ari Y. The K+ channel opener diazoxide enhances glutamatergic currents and reduces GABAergic currents in hippocampal neurons. Neurophysiology 1993; 69(2): 494-503.
35. Csonka C, Onody A, Csont T, Ferdinandy P. Defibrillatory action of glibenclamide is independent from ATP-sensitive K+ channels and free radicals. J Cardiovasc Pharmacol 2003; 41(6): 916-22.
36. Song Z, Routh VH. Recurrent hypoglycemia reduces the glucose sensitivity of glucose-inhibited neurons in the ventromedial hypothalamus nucleus. Am J Physiol Regul Integr Comp Physiol 2006; 291(5): R1283-7.
37. Song Z, Routh VH. Differential effects of glucose and lactate on glucosensing neurons in the ventromedial hypothalamic nucleus. Diabetes 2005; 54: 15-22.
38. Yang XJ, Kow LM, Pfaff DW, Mobbs CV. Metabolic pathways that mediate inhibition of hypothalamic neurons by glucose. Diabetes 2004; 53: 67-73.
39. McCrimmon RJ, Fan X, Cheng H, et al. Activation of AMP-activated protein kinase within the ventromedial hypothalamus amplifies counterregulatory hormone responses in rats with defective counterregulation. Diabetes 2006; 55(6): 1755-60.
40. Gadalla AE, Pearson T, Currie AJ, et al. AICA riboside both activates AMP-activated protein kinase and competes with adenosine for the nucleoside transporter in the CA1 region of the rat hippocampus. J Neurochem 2004; 88: 1272-82.
41. McCrimmon RJ, Song Z, Cheng H, et al. Corticotrophin-releasing factor receptors within the ventromedial hypothalamus regulate hypoglycemia-induced hormonal counterregulation. J Clin Invest 2006; 116(6): 1723-30.
42. Cheng H, Zhou L, Zhu W, et al. Type 1 corticotropin-releasing factor receptors in the ventromedial hypothalamus promote hypoglycemia-induced hormonal counterregulation. Am J Physiol Endocrinol Metab 2007; 293(3): E705-12.
43. Brown M R, Fisher L A, Webb V, Vale WW, Rivier JE. Corticotropin-releasing factor: a physiologic regulator of adrenal epinephrine secretion. Brain Res 1985; 328: 355-7.
44. Yokotani K, Murakami Y, Okada S, Hirata M. Role of brain arachidonic acid cascade on central CRF1 receptor-mediated activation of sympatho-adrenomedullary outflow in rats. Eur J Pharmacol 2001; 419(2-3): 183-9.
45. Levin BE, Becker TC, Eiki J, Zhang BB, Dunn-Meynell AA. Ventromedial hypothalamic glucokinase is an important mediator of the counterregulatory response to insulin-induced hypoglycemia. Diabetes 2008; 57(5): 1371-9.
46. Levin BE, Routh VH, Kang L, Sanders NM, Dunn-Meynell AA. Neuronal glucosensing: what do we know after 50 years? Diabetes 2004; 53(10): 2521-8.
47. Dunn-Meynell AA, Routh VH, Kang L, Gaspers L, Levin BE. Glucokinase is the likely mediator of glucosensing in both glucose-excited and glucose-inhibited central neurons. Diabetes 2002; 51(7): 2056-65.
48. Kang L, Sanders NM, Dunn-Meynell AA, et al. Prior Hypoglycemia Enhances Glucose Responsiveness in Some Ventromedial Hypothalamic Glucosensing Neurons. Am J Physiol Regul Integr Comp Physiol 2008; 294: R784-R92.
49. Adamson U, Lins P-E, Grill V. Fasting for 72 h decreases the response of counterregulatory hormones to insulin-induced hypoglycaemia in normal man. Scand J Clin Lab Invest 1989; 49: 751-6.
50. Teves D, Videen TO, Cryer PE, Powers WJ. Activation of human medial prefrontal cortex during autonomic responses to hypoglycemia. Proc Natl Acad Sci USA 2004; 101(16): 6217-21.
51. Musen G, Simonson DC, Bolo NR, et al. Regional Brain Activation during Hypoglycemia in Type 1 Diabetes. J Clin Endocrinol Metab 2008; 93(4): 1450-7.
52. Neafsey EJ. Prefrontal cortical control of the autonomic nervous system: anatomical and physiological observations. Prog Brain Res 1990; 85: 147-65.
53. Bingham EM, Dunn JT, Smith D, et al. Differential changes in brain glucose metabolism during hypoglycaemia accompany loss of hypoglycaemia awareness in men with type 1 diabetes mellitus. An 11C-3-O-methyl-D-glucose PET study. Diabetologia 2005; 48(10): 2080-9.
54. Dunn JT, Cranston I, Marsden PK, Amiel SA, Reed LJ. Attenuation of amydgala and frontal cortical responses to low blood glucose concentration in asymptomatic hypoglycemia in type 1 diabetes: a new player in hypoglycemia unawareness? Diabetes 2007; 56(11): 2766-73.
55. Arbelaez AM, Powers WJ, Videen TO, Price JL, Cryer PE. Attenuation of counterregulatory responses to recurrent hypoglycemia by active thalamic inhibition: a mechanism for hypoglycemia-associated autonomic failure. Diabetes 2008; 57(2): 470-5.
56. Saberi M, Bohland M, Donovan CM. The locus for hypoglycemic detection shifts with the rate of fall in glycemia: the role of portal-superior mesenteric vein glucose sensing. Diabetes 2008; 57(5): 1380-6.
57. Matveyenko AV, Bohland M, Saberi M, Donovan CM. Portal vein hypoglycemia is essential for full induction of hypoglycemia-associated autonomic failure with slow-onset hypoglycemia. Am J Physiol Endocrinol Metab 2007; 293(3): E857-64.
58. Donovan CM, Hamilton-Wessler M, Halter JB, Bergman RN. Primacy of liver glucosensors in the sympathetic response to progressive hypoglycemia. Proc Natl Acad Sci USA 1994; 91(7): 2863-7.
59. Young JB, Landsberg L. Sympathoadrenal activity in fasting pregnant rat. Dissociation of adrenal medullary and sympathetic nervous system responses. Clin Invest 1979; 64(1): 109-16.
60. Vollmer RR, Balcita JJ, Sved AF, Edwards DJ. Adrenal epinephrine and norepinephrine release to hypoglycemia measured by microdialysis in conscious rats. Am J Physiol 1997; 273(5 Pt 2): R1758-63.
61. Shimizu N, Oomura Y, Novin D, Grijalva CV, Cooper PH. Functional correlations between lateral hypothalamic glucose-sensitive neurons and hepatic portal glucose-sensitive units in rat. Brain Res 1983; 265(1): 49-54.
62. Timo-Iaria C. Glucoreceptor Systems: From Control of Glycemia to Feeding Behavior. News Physiol Sci 1990; 5(2): 46-9.
63. Bolli GB, Gottesman IS, Cryer PE, Gerich JE. Glucose counterregulation during prolonged hypoglycemia in normal humans. Am J Physiol 1984; 247(2 Pt 1): E206-14.
64. Oomura Y, Kimura K, Ooyama H, Maeo T, Iki M, Kuniyoshi N. Reciprocal activities of ventromedial and lateral hypothalamic areas of cats. Science 1964; 143: 484-5.
65. Arees E A, Mayer J. Anatomical connections between medial and lateral regions of the hypothalamus concerned with food intake. Science 1967; 157: 1574-5.
66. King BM. The rise, fall, and resurrection of the ventromedial hypothalamus in the regulation of feeding behavior and body weight. Physiol Behav 2006; 87(2): 221-44.
67. Cheu JW, Siegel A. GABA receptor mediated suppression of defensive rage behavior elicited from the medial hypothalamus of the cat: role of the lateral hypothalamus. Brain Res 1998; 783(2): 293-304.
68. Katafuchi T, Yoshimatsu H, Oomura Y, Sato A. Responses of adrenal catecholamine secretion to lateral hypothalamic stimulation and lesion in rats. Brain Res 1986; 363(1): 141-4.
69. Yoshimatsu H, Oomura Y, Katafuchi T, Niijima A, Sato A. Lesions of the ventromedial hypothalamic nucleus enhance sympathoadrenal function. Brain Res 1985; 339: 390-2.
70. Dagogo-Jack S, Rattarasarn C, Cryer PE. Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM. Diabetes 1994; 43(12): 1426-34.
71. Davis SN, Shavers C, Costa F. Differential gender responses to hypoglycemia are due to alterations in CNS driveand not glycemic thresholds. Am J Physiol Endocrinol Metab 2000; 279(5): E1054-63.
72. Yoshimatsu H, Oomura Y, Katafuchi T, Niijima A. Effects of hypothalamic stimulation and lesion on adrenal nerve activity. Am J Physiol 1987; 253(3 Pt 2): R418-24.
73. Saito M, Minokoshi Y, Shimazu T. Accelerated norepinephrine turnover in peripheral tissues after ventromedial hypothalamic stimulation in rats. Brain Res 1989; 481: 298-303.
74. Sakurai T. The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness. Nat Rev Neurosci 2007; 8(3): 171-81.
75. Orsini JC, Himmi T, Wiser AK, Perrin J. Local versus indirect action of glucose on the lateral hypothalamic neurons sensitive to glycemic level. Brain Res Bull 1990; 25(1): 49-53.
76. Cai XJ, Evans ML, Lister CA, et al. Hypoglycemia activates orexin neurons and selectively increases hypothalamic orexin-B levels: responses inhibited by feeding and possibly mediated by the nucleus of the solitary tract. Diabetes 2001; 50(1): 105-12.
77. Cai XJ, Widdowson PS, Harrold J, et al. Hypothalamic orexin expression: modulation by blood glucose and feeding. Diabetes 1999; 48(11): 2132-7.
78. Matsumura K, Tsuchihashi T, Abe I. Central orexin-A augments sympathoadrenal outflow in conscious rabbits. Hypertension 2001; 37(6): 1382-7.
79. Niijima A. Neural mechanisms in the control of blood glucose concentration. J Nutr 1989; 119(6): 833-40.
80. Niijima A. Glucose-sensitive afferent nerve fibers in the liver and their role in food intake and blood glucose regulation. J Auton Nerv Syst 1983; 9(1): 207-20.
81. Gotoh M, Hirroka, Y, Iguchi A, et al. Hyperglycaemia responses to central cholinergic stimulation: Possible implication of the central noradrenergic drive. In: Shimazu T. Ed. Liver Innervation and the Neural Control of Hepatic Function. London: Libbey, 1996; 205-12.
82. Nonogaki K, Iguchi A. Role of central neural mechanisms in the regulation of hepatic glucose metabolism. Life Sci 1997; 60(11): 797-807.
83. Wu M, Zaborszky L, Hajszan T, van den Pol AN, Alreja M. Hypocretin/ orexin innervation and excitation of identified septohippocampal cholinergic neurons. J Neurosci 2004; 24(14): 3527-36.
84. Nonogaki K, Iguchi A, Yatomi A, et al. Dissociation of hyperthermic and hyperglycemic effects of central prostaglandin F2 alpha. Prostaglandins 1991; 41(5): 451-62.
85. Inoue M, Crofton JT, Share L. Interactions between brain acetylcholine and prostaglandins in control of vasopressin release. Am J Physiol 1991; 261(2 Pt 2): R420-6.
86. Karanth S, Lyson K, McCann SM. Role of nitric oxide in interleukin 2-induced corticotropin-releasing factor release from incubated hypothalami. Proc Natl Acad Sci USA 1993; 90(8): 3383-7.
87. Okada S, Murakami Y, Yokotani K. Role of brain thromboxane A2 in the release of noradrenaline and adrenaline from adrenal medulla in rats. Eur J Pharmacol 2003; 467(1-3): 125-31.
88. Madden CJ, Stocker SD, Sved AF. Attenuation of homeostatic responses to hypotension and glucoprivation after destruction of catecholaminergic rostral ventrolateral medulla neurons. Am J Physiol Regul Integr Comp Physiol 2006; 291(3): R751-9.
89. Silveira SA, Viana Lima NR, Haibara AS, Coimbra CC. The hypothalamic paraventricular nucleus and carotid receptors modulate hyperglycemia induced by hemorrhage. Brain Res 2003; 993(1-2): 183-91.
90. Hermanns N, Kubiak T, Kulzer B, Haak T. Emotional changes during experimentally induced hypoglycaemia in type 1 diabetes. Biol Psychol 2003; 63(1): 15-44.
91. Whalen PJ, Rauch SL, Etcoff NL, McInerney SC, Lee MB, Jenike MA. Masked presentations of emotional facial expressions modulate amygdala activity without explicit knowledge. J Neurosci 1998; 18(1): 411-8.
92. Asahina M, Suzuki A, Mori M, Kanesaka T, Hattori T. Emotional sweating response in a patient with bilateral amygdala damage. Int J Psychophysiol 2003; 47(1): 87-93.
93. Liotti M, Brannan S, Egan G, et al. Brain responses associated with consciousness of breathlessness (air hunger). Proc Natl Acad Sci USA 2001; 98(4): 2035-40.
94. Kent JM, Coplan JD, Mawlawi O, et al. Prediction of panic response to a respiratory stimulant by reduced orbitofrontal cerebral blood flow in panic disorder. Am J Psychiatry 2005; 162(7): 1379-81.
95. Goehler LE, Lyte M, Gaykema RP. Infection-induced viscerosensory signals from the gut enhance anxiety: implications for psychoneuroimmunology. Brain Behav Immun 2007; 21(6): 721-6.
96. Mayer EA, Naliboff BD, Craig AD. Neuroimaging of the brain-gut axis: from basic understanding to treatment of functional GI disorders. Gastroenterology 2006; 131(6): 1925-42.
97. Craig AD. How do you feel? Interoception: the sense of the physiological condition of the body. Nat Rev Neurosci 2002; 3(8): 655-66.
98. Rempel-Clower NL. Role of orbitofrontal cortex connections in emotion. Ann NY Acad Sci 2007; 1121: 72-86.
99. Milad MR, Rauch SL. The role of the orbitofrontal cortex in anxiety disorders. Ann NY Acad Sci. 2007; 1121: 546-61.
100. Bishop SJ. Neurocognitive mechanisms of anxiety: an integrative account. Trends Cogn Sci 2007; 11(7): 307-16.
101. LeDoux J. The amygdala. Curr Biol 2007; 17(20): R868-74.
102. Williams LM, Liddell BJ, Kemp AH, et al. Amygdala-prefrontal dissociation of subliminal and supraliminal fear. Hum Brain Mapp 2006; 27(8): 652-61.
103. Cavada C, Company T, Tejedor J, Cruz-Rizzolo RJ, Reinoso-Suárez F. The anatomical connections of the macaque monkey orbitofrontal cortex. A review. Cereb Cortex 2000; 10(3): 220-42.
104. Oomura Y, Yoshimatsu H. Neural network of glucose monitoring system. J Auton Nerv Syst 1984; 10(3-4): 359-72.
105. Waagepetersen HS, Bakken IJ, Larsson OM, Sonnewald U, Schousboe A. Comparison of lactate and glucose metabolism in cultured neocortical neurons and astrocytes using 13C-NMR spectroscopy. Dev Neurosci 1998; 20(4-5): 310-20.
106. Duarte JM, Cunha RA, Carvalho RA. Different metabolism of glutamatergic and GABAergic compartments in superfused hippocampal slices characterizedby nuclear magnetic resonance spectroscopy. Neuroscience 2007; 23; 144(4): 1305-13.
107. Tarasenko AS, Linetska MV, Storchak LG, Himmelreich NH. Effectiveness of extracellular lactate/pyruvate for sustaining synaptic vesicle proton gradient generation and vesicular accumulation of GABA. J Neurochem 2006; 99(3): 787-96.
108. Pierre K, Debernardi R, Magistretti PJ, Pellerin L. Noradrenaline enhances monocarboxylate transporter 2 expression in cultured mouse cortical neurons via a translational regulation. J Neurochem 2003; 86(6): 1468-76.
109. Li Y, van den Pol AN. Direct and indirect inhibition by catecholamines of hypocretin/orexin neurons. J Neurosci 2005; 25: 173-83.
110. Yamanaka A, Muraki Y, Ichiki K, et al. Orexin neurons are directly and indirectly regulated by catecholamines in a complex manner. J Neurophysiol 2006; 96(1): 284-98.
111. Beverly JL, de Vries MG, Beverly MF, Arseneau LM. Norepinephrine mediates glucoprivic-induced increase in GABA in the ventromedial hypothalamus of rats. Am J Physiol Regul Integr Comp Physiol 2000; 279(3): R990-6.
112. de Vries MG, Lawson MA, Beverly JL. Hypoglycemia-induced noradrenergic activation in the VMH is a result of decreased ambient glucose. Am J Physiol Regul Integr Comp Physiol 2005; 289(4): R977-81.
113. Barbeito L, Fernandez C, Silveira R, Dajas F. Evidences of a sympatho-adrenal dysfunction after lesion of the central noradrenergic pathways in rats. J Neural Transm 1986; 67(3-4): 205-14.
114. Iadecola C. Astrocytes take center stage in salt sensing. Neuron 2007; 54(1): 3-5.
115. Takahashi A, Ishimaru H, Ikarashi Y, Kishi E, Maruyama Y. Hypothalamic cholinergic and noradrenergic neurons in hyperglycemia induced by 2-deoxyglucose. Brain Res 1994; 665(1): 13-7.
116. Canabal DD, Potian JG, Duran RG, McArdle JJ, Routh VH. Hyperglycemia impairs glucose and insulin regulation of nitric oxide production in glucose-inhibited neurons in the ventromedial hypothalamus. Am J Physiol Regul Integr Comp Physiol 2007; 293(2): R592-600.
117. Sotirov E, Papasova M. Nitric oxide modulates release of noradrenaline in guinea-pig gastric fundus. Brain Res Bull 2000; 51(5): 401-5.
118. Magistretti PJ, Allaman I. Glycogen: a Trojan horse for neurons. Nat Neurosci 2007; 10(11): 1341-2.
119. Kim J, Gorman JM. Psychobiology of anxiety. Clin Neuro Res 2005; 4(5-6): 335-47.
120. Dazzi L, Ladu S, Spiga F, et al. Chronic treatment with imipramine or mirtazapine antagonizes stress- and FG7142-induced increase in cortical norepinephrine output in freely moving rats. Synapse 2002; 43(1): 70-7.
121. Gorman AL, Dunn AJ. Beta-adrenergic receptors are involved in stress-related behavioral changes. Pharmacol Biochem Behav 1993; 45(1): 1-7.
122. Lapiz MD, Morilak DA. Noradrenergic modulation of cognitive function in rat medial prefrontal cortex as measured by attentional set shifting capability. Neuroscience 2006; 137(3): 1039-49.
123. Elam M, Thorén P, Svensson TH. Locus coeruleus neurons and sympathetic nerves: activation by visceral afferents. Brain Res 1986; 375(1): 117-25.
124. Korf J, Aghajanian GK, Roth RH. Increased turnover of norepinephrine in the rat cerebral cortex during stress: role of the locus coeruleus. Neuropharmacology 1973; 12: 933-8.
125. Grachev ID, Apkarian AV. Anxiety in healthy humans is associated with orbital frontal chemistry. Mol Psychiatry 2000; 5(5): 482-8.
126. Smith A, Sturgess W, Gallagher J. Effects of a low dose of caffeine given in different drinks on mood and performance. Hum Psychopharmacol 1999; 14: 473-82.
127. Baldwin HA, File SE. Caffeine-induced anxiogenesis: the role of adenosine, benzodiazepine and noradrenergic receptors. Pharmacol Biochem Behav 1989; 32(1): 181-6.
128. Goldberg MR, Curatolo PW, Tung CS, Robertson D. Caffeine down-regulates beta adrenoreceptors in rat forebrain. Neurosci Lett 1982; 31(1): 47-52.
129. White J R Jr., PharmD PA. Contribution of Medications to Hypoglycaemia Unawareness. Diabetes Spectrum 2000; 20 (2): 77-80.
130. Yuan PQ, Yang H. Neuronal activation of brain vagal-regulatory pathways and upper gut enteric plexuses by insulin hypoglycaemia. Am J Physiol Endocrinol Metabol 2002; 283(3): E436-E48.
131. Morilak DA, Fornal CA, Jacobs BL. Effects of physiological manipulations on locus coeruleus neuronal activity in freely moving cats. III. Glucoregulatory challenge. Brain Res 1987; 422(1): 32-9.
132. Flügge G. Regulation of monoamine receptors in the brain: dynamic changes during stress. Int Rev Cytol 2000; 195: 145-213.
133. Stone EA, Platt JE. Brain adrenergic receptors and resistance to stress. Brain Res 1982; 237(2): 405-14.
134. Nomura S, Watanabe M, Ukei N, Nakazawa T. Stress and beta-adrenergic receptor binding in the rat's brain. Brain Res 1981; 224(1): 199-203.
135. Funk D, Stewart J. Role of catecholamines in the frontal cortex in the modulation of basal and stress-induced autonomic output in rats. Brain Res 1996; 741(1-2): 220-9.
136. Ramos BP, Arnsten AF. Adrenergic pharmacology and cognition: focus on the prefrontal cortex. Pharmacol Ther 2007; 113(3): 523-36.
137. Kerr D, MacDonald IA, Heller SR, Tattersall RB. Beta-adrenoceptor blockade and hypoglycaemia. A randomised, double-blind, placebo controlled comparison of metoprolol CR, atenolol and propranolol LA in normal subjects. Br J Clin Pharmacol 1990; 29(6): 685-93.
138. Chalon S, Berlin I, Sachon C, Bosquet F, Grimaldi A. Propranolol in hypoglycaemia unawareness. Diabetes Metab 1999; 25(1): 23-6.
139. Baron BM, Ogden AM, Siegel BW, Stegeman J, Ursillo RC, Dudley MW. Rapid down regulation of beta-adrenoceptors by co-administration of desipramine and fluoxetine. Eur J Pharmacol 1988; 154(2): 125-34.
140. Roth NS, Campbell PT, Caron MG, Lefkowitz RJ, Lohse MJ. Comparative rates of desensitization of beta-adrenergic receptors by the beta-adrenergic receptor kinase and the cyclic AMP-dependent protein kinase. Proc Natl Acad Sci USA 1991; 88(14): 6201-4.
141. Vavaiya KV, Paranjape SA, Patil GD, Briski KP. Vagal complex monocarboxylate transporter-2 expression during hypoglycemia. Neuroreport 2006; 17(10): 1023-6.
142. Scheurink AJ, Steffens AB, Gaykema RP. Hypothalamic adrenoceptors mediate sympathoadrenal activity in exercising rats. Am J Physiol 1990; 259(3 Pt 2): R470-7.
143. Ohiwa N, Saito T, Chang H, Nakamura T, Soya H. Differential responsiveness of c-Fos expression in the rat medulla oblongata to different treadmill running speeds. Neurosci Res 2006; 54(2): 124-32.
144. Chase HP. Nocturnal hypoglycemia: an unrelenting problem. J Clin Endocrinol Metab 2006; 91: 2038-39.
145. Beregszèszi M, Tubiana-Rufi N, Benali K, Noël M, Bloch J, Czernichow P. Nocturnal hypoglycemia in children and adolescents with insulin-dependent diabetes mellitus: prevalence and risk factors. J Pediatr 1997; 131(1 Pt 1): 27-33.
146. Jones TW, Porter P, Sherwin RS, et al. Decreased epinephrine responses to hypoglycemia during sleep. N Engl J Med 1998; 338: 1657-62.
147. Schultes B, Jauch-Chara K, Gais S, et al. Defective awakening response to nocturnal hypoglycemia in patients with type 1 diabetes mellitus. PLoS Med 2007; 4: e69.
148. Gais S, Born J, Peters A, et al. Hypoglycemia counterregulation during sleep. Sleep 2003; 26: 55-9.
149. Niijima A, Nagai K, Nagai N, Nakagawa H. Light enhances sympathetic and suppresses vagal outflows and lesions including the suprachiasmatic nucleus eliminate these changes in rats. J Auton Nerv Syst 1992; 40(2): 155-60.
150. Niijima A, Chun SJ, Shima T, Bizot-Espiard JG, Guardiola-Lemaitre B, Nagai K. Effect of intravenous administration of melatonin on the efferent activity of the adrenal nerve. J Auton Nerv Syst 1998; 71(2-3): 134-8.
151. Paranjape SA, Vavaiya KK, Kale AY, Briski KP. Habituation of insulin-induced hypoglycaemic transcription activation of lateral hypothalamic orexin-A-containing neurons to recurring exposure. Regul Pept 2006; 135(1-2): 1-6.
152. Bourgin P, Huitron-Résendiz S, Spier AD, et al. Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons. J Neurosci 2000; 20(20): 7760-5.
153. Hagan JJ, Leslie RA, Patel S, et al. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc Natl Acad Sci USA 1999; 96(19): 10911-6.
154. Nishino S. The hypothalamic peptidergic system, hypocretin/orexin and vigilance control. Neuropeptides 2007; 41(3): 117-33.
155. Howorka K, Heger G, Schabmann A, Anderer P, Tribl G, Zeitlhofer J. Severe hypoglycaemia unawareness is associated with an early decrease in vigilance during hypoglycaemia. Psychoneuroendocrinology 1996; 21(3): 295-312.
156. Deadwyler SA, Porrino L, Siegel JM, Hampson RE. Systemic and nasal delivery of orexin-A (Hypocretin-1) reduces the effects of sleep deprivation on cognitive performance in nonhuman primates. J Neurosci 2007; 27(52): 14239-47.
157. Barsh GS, Schwartz MW. Genetic approaches to studying energy balance: perception and integration. Nat Rev Genet 2002; 3(8): 589-600.